People: Research Team

Professor Duncan Jodrell, DM MSc FRCP(Edin.) – Researcher and Medical Oncologist, co-lead

Duncan is the Professor of Cancer Therapeutics at the University of Cambridge and a Senior Group Leader at the Cancer Research UK Cambridge Institute. He is also the Cambridge Experimental Cancer Medicine Centre (ECMC) Lead, Director of the Cambridge Cancer Trials Centre (CCTC) and an honorary consultant at Addenbrooke’s Hospital.

Read More
Dr. Giulia Biffi, co-lead

Giulia Biffi is a group leader at the Cancer Research UK Cambridge Institute, University of Cambridge. Her laboratory works to understand the biology of pancreatic cancer, with aim of identifying more effective treatments for patients.

Read More
Professor Ashok Venkitaraman, Ursula Zoellner Professor; Director, MRC Cancer Cell Unit

Ashok Venkitaraman holds the Ursula Zoellner Professorship of Cancer Research at the University of Cambridge, and is the Director of the Medical Research Council (MRC) Cancer Cell Unit. He leads a multidisciplinary initiative that aims to pioneer new approaches for chemical biology and the development of small-molecule therapeutics.

Read More
Dr. Martin L Miller MSc PhD

Martin is a Junior Group Leader at the Cancer Research UK Cambridge Institute. His research is focused on cell-cell interactions in the tumour microenvironment and unravelling stroma-mediated drug resistance in human cancers using proteomic technologies.

Read More
Dr. Frances Richards

Frances Richards is the Pharmacology & Drug Development Group (Jodrell Group) Lab Head in the Cancer Research UK Cambridge Institute. With a background in cancer genetics and in drug discovery, she leads research projects focussed on preclinical development of drug combinations for treatment of pancreatic cancer.

Read More
Dr. Tim Halim

Tim is a group leader at the Cancer Research UK – Cambridge Institute, University of Cambridge. The Halim laboratory focusses on innate lymphoid cell (ILC) biology, and how innate immunity interacts locally with immune and non-immune cells in the pancreas.

Read More
Professor Jason Carroll

Jason Carroll is a Professor of Molecular Oncology at the University of Cambridge, a Senior Group Leader at Cancer Research UK, a Fellow at Clare College and was elected an EMBO member in 2016 and a Fellow of the Academy of Medical Sciences in 2017. His lab is interested in understanding mechanisms of hormone-dependent cancer.

Read More
Dr. Trevor Littlewood – Research scientist

Trevor co-runs (with Professor Gerard Evan) an academic research group at the University of Cambridge, department of biochemistry. Trevor’s interest in oncogenic signalling started at the Ludwig Institute for Cancer Research in the late 1980s and continued at the Imperial Cancer Research Fund (now CR UK), the MRC laboratory of Medical Biology and, since 2010, at the department of biochemistry.

Read More
Professor George Malliaras

George Malliaras is the Prince Philip Professor of Technology at the University of Cambridge. He is leading the EPSRC IRC on Targeted Delivery for Hard-to-Treat Cancers and works on electrophoretic drug delivery devices.

Read More
Dr. Michael (Mike) Gill

Mike is a Principle Scientific Associate in the Miller lab at the Cancer research UK- Cambridge Institute, University of Cambridge. My main research focus is centred around understanding the intercellular communication between heterogeneous pancreatic tumour cells, fibroblasts and macrophages, using multiple omics technologies.

Read More
Gerard Evan, Ph.D. Sir William Dunn Professor of Biochemistry

Gerard runs a research group focused on the elucidation of oncogene-mediated stromal changes and immune suppression in cancer and is the Sir William Dunn Professor and Head of the Department of Biochemistry.

Read More